Research Article

The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy

Table 3

Cytokine levels and laboratory results of the patients in the ADMSC group.

Treatment days
01357

Cytokines
IL-242.1 (28.5–304.9)76.0 (25.2–279.3)71.8 (40.0–273.6)59.0 (15.4–243.4)59.3 (45.0–258.0)0.516
IL-4418.4 (4.3–2597.5)298.8 (0.9–2639.8)210.0 (54.2–2390.8)280.8 (24.6–2602.5)417.5 (25.4–2716.7)0.404
IL-1018.5 (0.4–81.7)19.2 (9.6–84.3)15.9 (0.9–79.9)13.8 (8.2–83.0)13.4 (7.5–89.9)0.647
TNF-α105.5 (35.2–557.7)136.5 (68.7–564.8)140.6 (59.1–549.5)123.7 (59.1–612.7)99.0 (8.7–545.4)0.416
IF-Ɣ150.1 (82.2–814.6)166.0 (101.9–956.7)169.9 (109.5–953.7)172.2 (73.7–1029.4)181.4 (85.5–992.5)0.275
Laboratory results
CRP (mg/mL)207 (32–334)129 (99–279)96 (46–217)82 (20–275)75 (17–208)0.028
PCT (mg/mL)3.6 (0.7–100.0)3.1 (1.2–50.0)2.8 (1.3–10.0)2.2 (0.5–100.0)1.6 (0.5–56.0)0.641
WBC (µ/L)17100 (3070–41800)14840 (2750–39470)12715 (2820–46570)11190 (1990–40310)11440 (2210–36940)0.045
Lactate (mmol/L)1.43 (0.82–3.17)1.40 (1.09–2.20)1.33 (0.99–2.29)1.30 (0.63–2.84)1.30 (0.80–4.84)0.170
SOFA score (adjusted)3.02 ± 0.842.7 ± 0.832.48 ± 0.751.99 ± 1.082.2 ± 0.780.027 adjusted